-
-
-
-
-
-
-
bioAffinity Technologies reports 87% jump in lung cancer test revenue
-
-
-
-
-
-
-
bioAffinity Technologies Reports First Quarter 2025 Results
-
-
-
-
-
-
-
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
-
-
-
-
-
-
-
bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
-
-
-
-
-
-
-
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
-
1,205,340 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

